Trials / Completed
CompletedNCT00384722
EASYTRAK 3 Downsize Lead
EASYTRAK® 3 Downsize Lead Clinical Investigation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the EASYTRAK 3 Downsize Lead.
Detailed description
This is a prospective, non-randomized, multi-center US clinical investigation, designed to demonstrate the safety and effectiveness of the Guidant EASYTRAK 3 Downsize Lead in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EASYTRAK 3 Downsize Lead | EASYTRAK 3 Downsize Lead |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-07-01
- Completion
- 2008-05-01
- First posted
- 2006-10-06
- Last updated
- 2009-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00384722. Inclusion in this directory is not an endorsement.